Middle East and Asia Pacific Cell and Gene Therapy Market
- 2026 年市場規模
- USD 41.3 Bn
- 2033 年預估規模
- USD 68.7 Bn
- 年複合成長率 CAGR
- 11.8%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Middle East and Asia Pacific Cell and Gene Therapy Market, By Therapy Type (Cell Therapy (Stem Cells, T Cells, Dendritic Cells, and NK Cells) and Gene Therapy (Germline Gene Therapy and Somatic Gene Therapy)), By Indication (Dermatology, Musculoskeletal, Oncology, Immunology, Cardiology & Neurology, and Others), By Technology (Lentiviral Vector, Plasmid DNA, and AAV), By Geography (Middle East & Asia Pacific)
報告摘要
Cell therapy is the administration of living cells in patients for the treatment of a disease such as oncology, Immunology and others. The source of a cell can be autologous or allogeneic, which can be derived from stem cells such as bone marrow. Stem cells therapy is used in bone marrow transplantation. Gene therapy is the introduction, removal, or change in the patient's genetic code for the treatment of a disease. Moreover, it modifies the expression of an individual’s genes or repairs abnormal genes. The therapy involves the administration of nucleic acid (DNA/RNA) with carriers called vectors.
Market Dynamics
Key players are focusing on product approvals and launches to strengthen their position in the Middle East and Asia Pacific cell and gene therapy market. For instance, in March 2021, Novartis received Singapore Health Sciences Authority (HSA) approval for Kymriah (tisagenlecleucel), as the first commercial chimeric antigen receptor T-cell (CAR-T) therapy in Singapore under the new cell, tissue, and gene therapy products (CTGTP) regulatory framework.
Furthermore, in February 2021, the commercial manufacturing of Novartis’s Kymriah was approved by Therapeutic Goods Administration (TGA) in Australia.
Key features of the study
• This report provides an in-depth analysis of the Middle East and Asia Pacific cell and gene therapy market, provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Middle East and Asia Pacific cell and gene therapy market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Novartis International AG, Pfizer, Inc., Sanofi S.A., Amgen, Inc., Regeneron Pharmaceuticals, Inc., F. Hoffmann-La Roche AG, Bluebird Bio, Inc. (Celgene Corporation), Gene biotherapeutics, Sibiono GeneTech Co. Ltd., Kolon TissueGene, Inc., Horama S.A., MeiraGTx Limited, Gilead Sciences, Inc., Biogen INC., Organogenesis, Inc., JCR Pharmaceuticals Co. Ltd, uniQure N.V., WuxiAppTec, Lonza, and Immuneel Therapeutics Pvt Ltd
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The Middle East and Asia Pacific cell and gene therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Middle East and Asia Pacific cell and gene therapy market
Market Segmentation
• By Therapy Type
o Cell Therapy
Stem Cells
T Cells
Dendritic Cells
NK Cells
o Gene Therapy
Germline Gene Therapy
Somatic Gene Therapy
• By Indication
o Dermatology
o Musculoskeletal
o Oncology
o Immunology
o Cardiology & Neurology
o Others
• By Technology
o Lentiviral Vector
o Plasmid DNA
o AAV
• By Region
o Middle East
GCC Countries
Israel
Rest of Middle East
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
• Key Players Insights
o Novartis International AG
o Pfizer, Inc.
o Sanofi S.A.
o Amgen, Inc.
o Regeneron Pharmaceuticals, Inc.
o Hoffmann-La Roche AG
o Bluebird Bio, Inc. (Celgene Corporation)
o Gene biotherapeutics
o Sibiono GeneTech Co. Ltd.
o Kolon TissueGene, Inc.
o Horama S.A.
o MeiraGTx Limited
o Gilead Sciences, Inc.
o Biogen INC.
o Organogenesis, Inc.
o JCR Pharmaceuticals Co. Ltd
o uniQure N.V.
o WuxiAppTec
o Lonza
o Immuneel Therapeutics Pvt Ltd.
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Therapy Type
Market Snippet, By Indication
Market Snippet, By Technology
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Drivers
o Restraints
o Challenges in Cell and Gene Therapy
o Capital Intensive Process
o Opportunity
o Impact Analysis
o Adoptive T-cell’s Therapy Evolution
o Market Trends
o Regulatory Scenario
o Reimbursement Scenario
o Pipeline Analysis
o Partnership and Collaboration Scenario
o PEST Analysis
o PORTER’S Five Forces
o Epidemiology
o Company Market Share Analysis
4. Middle East and Asia Pacific Cell and Gene Therapy Market, By Therapy Type, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Cell Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Stem Cells
o T Cells
o Dendritic Cells
o NK Cells
o Gene Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Germline Gene Therapy
o Somatic Gene Therapy
5. Middle East and Asia Pacific Cell and Gene Therapy Market, By Indication, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Dermatology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Musculoskeletal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Oncology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Immunology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Cardiology & Neurology
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Middle East and Asia Pacific Cell and Gene Therapy Market, By Technology, 2026 - 2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021-2033
Segment Trends
o Lentiviral Vector
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o Plasmid DNA
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
o AAV
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Middle East and Asia Pacific Cell and Gene Therapy Market, By Region, 2026 – 2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2021–2033
o Middle East
Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
Market Size and Forecast, By Technology, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
o Asia Pacific
Market Size and Forecast, By Therapy Type, 2021-2033, (USD Bn)
Market Size and Forecast, By Indication, 2021-2033, (USD Bn)
Market Size and Forecast, By Technology, 2021-2033, (USD Bn)
Market Size and Forecast, By Country, 2021-2033, (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
8. Competitive Landscape
o Competitive Snapshot
Novartis International AG
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Pfizer, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Sanofi S.A.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Amgen, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Regeneron Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Hoffmann-La Roche AG
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Bluebird Bio, Inc. (Celgene Corporation)
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Gene biotherapeutics
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Sibiono GeneTech Co. Ltd.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Kolon TissueGene, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Horama S.A.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
MeiraGTx Limited
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Gilead Sciences, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Biogen INC.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Organogenesis, Inc.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
JCR Pharmaceuticals Co. Ltd
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
uniQure N.V.
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
WuxiAppTec
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Lonza
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Immuneel Therapeutics Pvt Ltd
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
9. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們